Literature DB >> 15371515

Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal.

Claudio Acuna-Goycolea1, Anthony van den Pol.   

Abstract

Glucagon-like peptide 1 (GLP-1) is produced by neurons in the caudal brainstem that receive sensory information from the gut and project to several hypothalamic regions involved in arousal, interoceptive stress, and energy homeostasis. GLP-1 axons and receptors have been detected in the lateral hypothalamus, where hypocretin neurons are found. The electrophysiological actions of GLP-1 in the CNS have not been studied. Here, we explored the GLP-1 effects on GFP (green fluorescent protein)-expressing hypocretin neurons in mouse hypothalamic slices. GLP-1 receptor agonists depolarized hypocretin neurons and increased their spike frequency; the antagonist exendin (9-39) blocked this depolarization. Direct GLP-1 agonist actions on membrane potential were abolished by choline substitution for extracellular Na+, and dependent on intracellular GDP, suggesting that they were mediated by sodium-dependent conductances in a G-protein-dependent manner. In voltage clamp, the GLP-1 agonist Exn4 (exendin-4) induced an inward current that reversed near -28 mV and persisted in nominally Ca2+-free extracellular solution, consistent with a nonselective cationic conductance. GLP-1 decreased afterhyperpolarization currents. GLP-1 agonists enhanced the frequency of miniature and spontaneous EPSCs with no effect on their amplitude, suggesting presynaptic modulation of glutamate axons innervating hypocretin neurons. Paraventricular hypothalamic neurons were also directly excited by GLP-1 agonists. In contrast, GLP-1 agonists had no detectable effect on neurons that synthesize melanin-concentrating hormone (MCH). Together, our results show that GLP-1 agonists modulate the activity of hypocretin, but not MCH, neurons in the lateral hypothalamus, suggesting a role for GLP-1 in the excitation of the hypothalamic arousal system possibly initiated by activation by viscera sensory input.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371515      PMCID: PMC6729787          DOI: 10.1523/JNEUROSCI.1607-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  50 in total

Review 1.  Central GLP-1 receptors: Novel molecular targets for cocaine use disorder.

Authors:  N S Hernandez; H D Schmidt
Journal:  Physiol Behav       Date:  2019-03-28

2.  Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior.

Authors:  Anne E Harasta; John M Power; Georg von Jonquieres; Tim Karl; Daniel J Drucker; Gary D Housley; Miriam Schneider; Matthias Klugmann
Journal:  Neuropsychopharmacology       Date:  2015-02-11       Impact factor: 7.853

3.  GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus.

Authors:  Xinmin Xie; Tara L Crowder; Akihiro Yamanaka; Stephen R Morairty; Robin D Lewinter; Takeshi Sakurai; Thomas S Kilduff
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

Review 4.  Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure.

Authors:  Linda Rinaman
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

5.  Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABAA and GABAB receptor-mediated synaptic input.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Neuropharmacology       Date:  2018-01-05       Impact factor: 5.250

Review 6.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

7.  Leptin acts via lateral hypothalamic area neurotensin neurons to inhibit orexin neurons by multiple GABA-independent mechanisms.

Authors:  Paulette B Goforth; Gina M Leinninger; Christa M Patterson; Leslie S Satin; Martin G Myers
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

Review 8.  Interoceptive modulation of neuroendocrine, emotional, and hypophagic responses to stress.

Authors:  James W Maniscalco; Linda Rinaman
Journal:  Physiol Behav       Date:  2017-01-14

Review 9.  Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions.

Authors:  Ambika Shandilya; Sidharth Mehan
Journal:  Neurol Sci       Date:  2021-05-21       Impact factor: 3.307

Review 10.  Neuropeptide transmission in brain circuits.

Authors:  Anthony N van den Pol
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.